Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
The Journal of Clinical Investigation|November 13, 2009
Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expressionJiann-Jyh Lai, Kuo-Pao Lai, Kuang-Hsiang Chuang, et al.Breast Cancer Research and Treatment|January 27, 2025
The Johns Hopkins Hope at Hopkins Clinic: supporting the comprehensive needs of individuals with metastatic breast cancerVered Stearns, Ruizhe Chen, Amanda L Blackford, et al.Plos Biology|October 22, 2013
Deciphering the structural basis of eukaryotic protein kinase regulationHiruy S Meharena, Philip Chang, Malik M Keshwani, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|September 18, 2013
A simple cost-saving measure: 2.5% mafenide acetate solutionAmir Ibrahim, Shawn Fagan, Tim Keaney, et al.Molecular Endocrinology (Baltimore, Md.)|December 20, 2012
Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacyKuo-Pao Lai, Jiann-Jyh Lai, Philip Chang, et al.Academic Radiology|July 27, 2012
Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal functionPhilip Chang, Elise Saddleton, Anne E Laumann, et al.Cancer Research|November 4, 2005
Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathwayJing Ni, Xingqiao Wen, Jorge Yao, et al.World Journal for Pediatric & Congenital Heart Surgery|June 28, 2013
Unoperated congenitally corrected transposition of the great arteries, nonrestrictive ventricular septal defect, and pulmonary stenosis in middle adulthood: do multiple wrongs make a right?Jerold S Shinbane, Jabi Shriki, Antereas Hindoyan, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|September 7, 2017
Resolvin D2 Limits Secondary Tissue Necrosis After Burn Wounds in RatsYoshitaka Inoue, Yuk Ming Liu, Masayuki Otawara, et al.Nature Communications|June 3, 2020
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancerKeliang Wang, Jie Luo, Shuyuan Yeh, et al.Pageof 5